Efficacy and safety of ixekizumab treatment in patients with axial spondyloarthritis: 2-year results from COAST

OBJECTIVES: To study the efficacy and safety of ixekizumab (IXE) in patients with radiographic (r-) and non-radiographic (nr-)axial spondyloarthritis (axSpA) for up to 116 weeks. METHODS: COAST-Y (NCT03129100) is the 2-year extension study following COAST-V, COAST-W and COAST-X. Patients were treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Jürgen, Kiltz, Uta, Deodhar, Atul, Tomita, Tetsuya, Dougados, Maxime, Bolce, Rebecca, Sandoval, David, Lin, Chen-Yen, Walsh, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301795/
https://www.ncbi.nlm.nih.gov/pubmed/35853675
http://dx.doi.org/10.1136/rmdopen-2021-002165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301795/
https://www.ncbi.nlm.nih.gov/pubmed/35853675
http://dx.doi.org/10.1136/rmdopen-2021-002165

Ejemplares similares